PMA device
Cordella Pulmonary Artery Sensor System
Endotronix, Inc. · System, Hemodynamic, Implantable (MOM, Class III) · First FDA decision Jun 20, 2024, newest Oct 29, 2026Heart failure
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
6
Naming "Cordella"
MAUDE reports
79
Brand "Cordella", since 2015
PubMed studies
29
Mentioning "Cordella"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cordella Pulmonary Artery Sensor System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- Cordella Pulmonary Artery Sensor SystemPMA supplement
P230040-S030 · Decided Oct 29, 2026 · 251 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hemodynamic, implantable (MOM) · Cardiology
- Cordella Pulmonary Artery Sensor System (CorPASS)PMA supplement
P230040-S010 · Decided Jan 17, 2025 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hemodynamic, implantable (MOM) · Cardiology
- Cordella Pulmonary Artery Sensor System (CorPASS)PMA supplement
P230040-S001 · Decided Oct 4, 2024 · 77 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hemodynamic, implantable (MOM) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cordella", any status and sponsor, newest update first.
- SIRONA 2 Trial Heart Failure NYHA Class IIIActive, not recruiting
Endotronix, Inc.Not on our public-company list
NCT04012944 · 81 participants · Start Jun 26, 2019 · Primary completion Oct 30, 2021
Device: Cordella™ Pulmonary Artery Sensor System · For: Heart Failure NYHA Class III
Sites: Aalst, Belgium; Genk, Belgium; Cologne, Germany · 7 sites in all
- PROACTIVE-HF IDE Trial Heart Failure NYHA Class IIIActive, not recruiting
Endotronix, Inc.Not on our public-company list
NCT04089059 · 738 participants · Start Jan 10, 2020 · Primary completion Apr 2028
Device: Cordella™ Pulmonary Artery Sensor System · For: Heart Failure NYHA Class III
Sites: Birmingham, Alabama; Huntsville, Alabama; Phoenix, Arizona · 74 sites in all
- PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and IIIPivotal-lookingRecruiting
Endotronix, Inc.Not on our public-company list
NCT05934487 · 1,750 participants (planned) · Start Nov 29, 2023 · Primary completion Sep 2028
Device: Cordella™ Pulmonary Artery Sensor System · For: Heart Failure NYHA Class II; Heart Failure NYHA Class III; Heart Failure
Sites: Phoenix, Arizona; Los Angeles, California; San Francisco, California · 48 sites in all
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cordella", and for the whole product code for context.
This brand
79 reports: 19 malfunction, 59 injury, 1 death
Whole product code MOM
12,295 reports: 7,687 malfunction, 4,377 injury, 226 death
Newest reports for this brand
3024985933-2026-00042 · Received Oct 23, 2026 · Event dated Oct 2, 2026
Device type: System, Hemodynamic, Implantable (MOM)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Cordella Pulmonary Artery Sensor SystemMalfunction
3024985933-2026-00039 · Received Sep 30, 2026 · Event dated Sep 16, 2026
Device type: System, Hemodynamic, Implantable (MOM)
Device problem as coded: Incorrect Measurement
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
3024985933-2026-00038 · Received Sep 24, 2026 · Event dated Sep 1, 2026
Device type: System, Hemodynamic, Implantable (MOM)
Device problem as coded: Incorrect Measurement
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Cordella"[tiab]. The summary above synthesizes these.
- Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure: Results of the PROACTIVE-HF Trial.
Guichard JL, Bonno EL, Nassif ME, et al. · JACC Heart Fail · 2024Clinical Trial, Multicenter Study
- Twelve-month follow-up results from the SIRONA 2 clinical trial.
Sharif F, Rosenkranz S, Bartunek J, et al. · ESC Heart Fail · 2024
- [Telemedicine in cardiology - what is new?].
Schneider D, Köhler K, Köhler F · Dtsch Med Wochenschr · 2023English Abstract
- A Procedural Guide for Implanting the Cordella Pulmonary Artery Pressure Sensor.
Guichard JL, Sharif F, Forouzan O, et al. · J Invasive Cardiol · 2023
- Clinical Characteristics and Outcomes in Heart Failure Patients with Implantable Pulmonary Artery Pressure Monitors: A Single Centre Irish Experience.
Leahy N, O'Brien C, Alsubai SE, et al. · J Cardiovasc Dev Dis · 2025
- Effects of dapagliflozin on congestion assessed by remote pulmonary artery pressure monitoring.
Mullens W, Martens P, Forouzan O, et al. · ESC Heart Fail · 2020Observational Study
- Safety and efficacy of a wireless pulmonary artery pressure sensor: primary endpoint results of the SIRONA 2 clinical trial.
Sharif F, Rosenkranz S, Bartunek J, et al. · ESC Heart Fail · 2022Clinical Trial, Multicenter Study
- Continuous positive airway pressure treatment improves bone mineral density in men affected by severe obstructive sleep apnea syndrome.
Carpi M, Cordella A, Placidi F, et al. · J Clin Sleep Med · 2024Observational Study, Research Support, Non-U.S. Gov't
- Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first-in-human study.
Mullens W, Sharif F, Dupont M, et al. · Eur J Heart Fail · 2020Clinical Trial, Multicenter Study
- Feasibility of Continuous Noninvasive Pulmonary Artery Pressure Monitoring via the Cordella Implantable Pulmonary Artery Sensor.
Mullens W, Rosenkranz S, Sharif F, et al. · JACC Heart Fail · 2024Letter
- Current and Future Landscape of Remote Hemodynamic Monitoring.
Klein L · J Card Fail · 2025Review, Research Support, Non-U.S. Gov't
- Seated Pulmonary Artery Pressure Management in Patients With Heart Failure: 12-Month Outcomes of the PROACTIVE-HF Trial.
Guichard JL, Bonno EL, Nassif ME, et al. · JACC Heart Fail · 2026Multicenter Study, Clinical Trial
Other devices of this type
Also filed under product code MOM.
- CardioMEMS HF SystemAbbott Medical · PMA 2026
- Cardiomems HF Pressure Measurement SystemAbbott Medical · PMA 2016
- Next Gen Patient System CM1200 CardioMEMS HERO DeviceAbbott Medical · PMA 2026
- CorPASS SystemEndotronix, Inc. · PMA 2025
- CardioMEMS patient and hospital electronicsAbbott Medical · PMA 2018
- CardiomemsAbbott Medical · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.